Kythera appoints Elisabeth Sandoval CCO
This article was originally published in Scrip
Executive Summary
Kythera Biopharmaceuticals, a privately-held biotech developing prescription products in aesthetic medicine, has named Elisabeth Sandoval chief commercial officer. Ms Sandoval has over 25 years' experience of the pharmaceutical and medical device industries, having spent 20 years at Allergan. She joins Kythera from Bausch + Lomb Surgical, where she most recently served as vice-president of global marketing & strategy.